Clinical Trial Update: Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial updates the effects of intravitreal ranibizumab on macular edema in nonproliferative diabetic retinopathy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Nonproliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Wonkwang University Hospital | Conditions: Nonproliferative Diabetic Retinopathy | Phase 4 | Status: COMPLETED | Results posted: 2020-04-22